<p><h1>Non-surgical Intragastric Balloon Market Size, Share & Trends Analysis Report By Material, By Type, By End-user, By Region, And Segment Forecasts, 2025 - 2032</h1></p><p><strong>Non-surgical Intragastric Balloon Market Analysis and Latest Trends</strong></p>
<p><p>The Non-surgical Intragastric Balloon is a weight-loss procedure that involves placing a soft, silicone balloon in the stomach through the mouth using an endoscope. Once inserted, the balloon is filled with saline or gas to occupy space in the stomach, promoting a feeling of fullness and reducing food intake. This non-invasive method is an alternative to bariatric surgery and is typically used for individuals with a BMI of 30-40 who struggle with obesity. The procedure is temporary, with the balloon removed after six months.</p><p>The Non-surgical Intragastric Balloon Market is experiencing significant growth, driven by the rising prevalence of obesity and increasing demand for minimally invasive weight-loss solutions. The market is expected to grow at a CAGR of 9.4% during the forecast period. Key factors contributing to this growth include advancements in balloon technology, improved safety profiles, and growing awareness about non-surgical weight-loss options. Additionally, the availability of customizable balloon systems and the expansion of healthcare infrastructure in emerging markets are fueling market expansion.</p><p>Recent trends in the market include the development of swallowable balloons that eliminate the need for endoscopy, enhancing patient convenience. There is also a growing focus on integrating digital health tools, such as mobile apps, to monitor patient progress and improve outcomes. The market is poised for further innovation, with companies investing in research to enhance efficacy and patient comfort.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliablemarketsize.com/enquiry/request-sample/684682?utm_campaign=973&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=20012025&utm_id=non-surgical-intragastric-balloon">https://www.reliablemarketsize.com/enquiry/request-sample/684682</a></p>
<p>&nbsp;</p>
<p><strong>Non-surgical Intragastric Balloon Major Market Players</strong></p>
<p><p>The non-surgical intragastric balloon market is highly competitive, with key players like **Allurion Technologies**, **Apollo Endosurgery**, **Endalis**, **Helioscopie**, and **ReShape Medical** driving innovation and growth. These companies focus on minimally invasive weight-loss solutions, catering to the rising demand for obesity management.</p><p>**Allurion Technologies** is a leader with its Elipse Balloon, the first swallowable, procedure-less gastric balloon. The company has seen significant market growth due to its unique no-endoscopy, no-anesthesia approach. Allurion’s global expansion and partnerships with healthcare providers have strengthened its position. The global obesity treatment market, valued at $12 billion in 2022, is expected to grow at a CAGR of 16.5%, with Allurion poised to capture a larger share.</p><p>**Apollo Endosurgery**, known for its Orbera Intragastric Balloon, is another major player. The company reported $51.6 million in revenue in 2022, driven by its strong presence in the U.S. and Europe. Apollo’s focus on R&D and strategic acquisitions has fueled its growth. The intragastric balloon market, projected to reach $1.2 billion by 2030, offers Apollo significant opportunities for expansion.</p><p>**ReShape Medical**, acquired by Obalon Therapeutics, specializes in the ReShape Integrated Dual Balloon System. Despite financial challenges, ReShape has maintained a niche market presence. Its revenue in 2022 was approximately $5 million, with potential for growth as the obesity treatment market expands.</p><p>**Helioscopie** and **Endalis** are emerging players, focusing on cost-effective solutions and regional markets. Helioscopie’s Spatz3 adjustable balloon and Endalis’s innovative designs are gaining traction, particularly in Europe and Asia.</p><p>Overall, the non-surgical intragastric balloon market is set for robust growth, driven by increasing obesity rates and advancements in medical technology. Companies like Allurion and Apollo are well-positioned to lead, while smaller players aim to carve out niches in this expanding market.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Non-surgical Intragastric Balloon Manufacturers?</strong></p>
<p><p>The non-surgical intragastric balloon market is experiencing robust growth, driven by rising obesity rates and increasing demand for minimally invasive weight-loss solutions. Valued at approximately $500 million in 2022, the market is projected to grow at a CAGR of 12-15% through 2030. Key drivers include advancements in balloon technology, improved safety profiles, and growing awareness of non-surgical options. North America and Europe dominate the market, but Asia-Pacific is emerging as a high-growth region due to expanding healthcare infrastructure. Future outlook remains positive, with innovations like swallowable balloons and AI-driven patient monitoring expected to further propel market expansion.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliablemarketsize.com/enquiry/pre-order-enquiry/684682?utm_campaign=973&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=20012025&utm_id=non-surgical-intragastric-balloon">https://www.reliablemarketsize.com/enquiry/pre-order-enquiry/684682</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Non-surgical Intragastric Balloon Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Sterile</li><li>Non-sterile</li></ul></p>
<p><p>The Non-surgical Intragastric Balloon market is categorized into Sterile and Non-sterile types based on product sterilization. Sterile intragastric balloons are pre-treated to eliminate microorganisms, ensuring safety and reducing infection risks, making them ideal for medical settings. Non-sterile balloons lack this treatment, often used in research or non-clinical applications. Sterile variants dominate the market due to higher safety standards in healthcare, while non-sterile options cater to cost-sensitive or experimental needs. Both types serve weight management purposes but differ in application and regulatory compliance.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliablemarketsize.com/purchase/684682?utm_campaign=973&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=20012025&utm_id=non-surgical-intragastric-balloon">https://www.reliablemarketsize.com/purchase/684682</a></p>
<p>&nbsp;</p>
<p><strong>The Non-surgical Intragastric Balloon Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospital</li><li>Clinic</li><li>Other</li></ul></p>
<p><p>The non-surgical intragastric balloon market serves hospitals, clinics, and other healthcare settings by offering a minimally invasive weight-loss solution. Hospitals utilize it for comprehensive obesity management, often integrating it with multidisciplinary care. Clinics provide accessible, outpatient procedures for patients seeking non-surgical weight-loss options. Other markets, such as specialized weight-loss centers or private practices, cater to individuals preferring personalized, non-hospital-based treatments. This device is widely adopted across these settings due to its safety, effectiveness, and suitability for patients ineligible for surgery.</p></p>
<p><a href="https://www.reliablemarketsize.com/non-surgical-intragastric-balloon-market-r684682?utm_campaign=973&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=20012025&utm_id=non-surgical-intragastric-balloon">&nbsp;https://www.reliablemarketsize.com/non-surgical-intragastric-balloon-market-r684682</a></p>
<p><strong>In terms of Region, the Non-surgical Intragastric Balloon Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The non-surgical intragastric balloon market is projected to experience robust growth across regions, with North America (NA) and Europe leading due to advanced healthcare infrastructure and rising obesity rates. NA is expected to dominate with a market share of approximately 40%, followed by Europe at 30%. The Asia-Pacific (APAC) region, particularly China, is anticipated to witness the fastest growth, driven by increasing awareness and healthcare investments, holding a 20% market share. The USA remains a key contributor within NA, reflecting its strong adoption of innovative weight-loss solutions.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliablemarketsize.com/purchase/684682?utm_campaign=973&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=20012025&utm_id=non-surgical-intragastric-balloon">https://www.reliablemarketsize.com/purchase/684682</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliablemarketsize.com/enquiry/request-sample/684682?utm_campaign=973&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=20012025&utm_id=non-surgical-intragastric-balloon">https://www.reliablemarketsize.com/enquiry/request-sample/684682</a></p>
<p><strong></strong></p>
<p>Check more reports on <a href="https://www.reliablemarketsize.com/?utm_campaign=973&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=20012025&utm_id=non-surgical-intragastric-balloon">https://www.reliablemarketsize.com/</a></p>